Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

232
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
232
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

194
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
194
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

186
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
186
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

683
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
683
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

557
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
557
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

200
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
200

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A case of mixed early gastric adenocarcinoma: blind spot of magnifying endoscopy with narrow-band imaging in detecting submucosal invasion.

iGIE : innovation, investigation and insights·2026
Same author

A mucosal lesion in the rectum: an unexpected mucosa-associated lymphoid tissue lymphoma.

iGIE : innovation, investigation and insights·2026
Same author

Targeting a Myeloid-Regulatory B Cell Network Reverses Immune Paralysis in Periprosthetic Joint Infections.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Detected residual venous thrombi and catheter-directed management of intermediate-risk pulmonary thromboembolism.

Frontiers in cardiovascular medicine·2026
Same author

Pathway for the Diagnosis and Management of Pericardial Disease: Contemporary Perspective.

Critical pathways in cardiology·2026
Same author

A rare solid tumor frequently misdiagnosed as lymphoma: primary colonic Epstein-Barr virus-positive inflammatory follicular dendritic cell sarcoma.

Virchows Archiv : an international journal of pathology·2026

関連する実験動画

Updated: Jan 5, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.8K

摘要 10613: 症状のあるヒト免疫不全ウイルスに感染した患者は,急性冠動脈症候群の後に,より積極的な再血管化管理を受け,全国的な5年間の分析

Claire Huang Lucas1, Lingling Wu2, Bing Yue3

  • 1Internal Medicine, Mount Sinai St Luke's-West Hosp, NYC, NY.

Circulation
|October 22, 2019
PubMed
まとめ
この要約は機械生成です。

急性冠動脈症候群 (ACS) の症状のあるHIV患者は,治療の格差を示唆する心臓再血管化は少ない. ACSを患った無症状のHIV患者は,対照群と比較して,手順において有意な違いを示さなかった.

キーワード:
既得免疫不全症候群急性冠動脈症候群冠動脈バイパス移植 (CABG)経皮冠動脈干渉 (PCI)

さらに関連する動画

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.2K
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

13.3K

関連する実験動画

Last Updated: Jan 5, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.8K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.2K
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

13.3K

科学分野:

  • 心臓病科
  • 感染症
  • 公衆衛生

背景:

  • 心血管疾患 (CVD) は,ヒト免疫不全ウイルス (HIV) を感染した成人の主要な死因です.
  • 過去の研究は,HIV患者の急性冠動脈症候群 (ACS) 治療における格差を示唆しています.
  • HIVに感染した成人の心血管疾患の治療は,積極的に行うことが推奨されます.

研究 の 目的:

  • ACSと診断されたHIV感染者の心臓再血管化の処置における治療の格差を調査する.
  • 症状のあるHIV,無症状のHIV,対照群の治療率を比較する.
  • 最近の大規模なコホートデータを利用し,包括的な分析を行う.

主な方法:

  • 2013年から2016年までの全国の入院患者サンプル (NIS) データベースの遡及レビュー.
  • ACS (ST上昇心筋梗塞,非ST上昇心筋梗塞,不安定な心痛) の患者の特定
  • 多変性回帰を用いた対照群,無症状HIV群,および症状HIV群における心血管キャセテリゼーション,皮膚冠動脈介入 (PCI),冠動脈バイパス移植 (CABG) 率の比較.

主要な成果:

  • 合計51万5千16人のACS患者が確認され,2066人 (0. 40%) がHIVと診断されました.
  • ACSの症状のあるHIV患者は,対照群と比較して,キャセテリゼーション (OR: 0. 62),PCI (OR: 0. 80) およびCABG (OR: 0. 70) の割合が著しく低下した.
  • ACSを患った無症状のHIV患者は,対照群と比較して,処置率の有意な差異を示さなかった.

結論:

  • ACSを患っている症状のあるHIV感染者の治療の格差は顕著で,アグレッシブな心臓管理の割合は低下しています.
  • ACSの無症状のHIV患者では,キャセテリゼーションとリバスカライゼーションの手順のこの差異は観察されなかった.
  • この発見はHIV感染者全員に 公平な心血管治療の必要性を強調しています